-
Study budgeting, feasibility studies, site recruitment
SynCRO has its own database with qualified investigators in different clinical specialties: oncology, cardiovascular medicine, diabetes, internal medicine, neurology, ophthalmology, E.N.T., orthopedic surgery and medical devices.
-
Regulatory affairs, ethic committees
+ Preparation of documents and submission to regulatory authorities and ECs
+ Timely reporting of SUSARs, SAEs. -
Drug import, site initiation
+ Drug import and distribution to centers
+ Site initiation / training of investigators -
Project management, study coordination, monitoring
+ Trial site management / site supplies (laboratory kits, CRFs)
+ Continuous assessment of investigators' compliance with GCP / regulatory requirements -
Clinical Data Management and Biostatistics
Syncro is providing Clinical Data Management and Biostatistics services through it's partner, AdWare Research.
AdWare Research was established in 1997 and it is a dynamically developing pre-clinical and clinical data-management and biostatistics provider company. AdWare provides its service in compliance with the national and international regulations, and possesses the relevant GLP, RA certificates.
+ Data-management and biostatistics
Its main activities are:
+ Quality assurance
+ Independent audit
+ Education and consultancyWith its strategic partners AdWare can undertake whole-scale project management.
The data-management services are provided by its own developed Mythos data-manager software that fulfills the criteria of FDA CFR 21 part 11.
For more information please visit: www.adwareresearch.com
-
27 MAR
2012News title here and it can go on two rows as an example
News preview line here. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Pellentesque ornare ipsum a ante porttitor congue. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Pellentesque ornare.
Read more -
11 NOV
2011News title here and it can go on two rows as an example 2
News preview line here. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Pellentesque ornare ipsum a ante porttitor congue. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Pellentesque ornare. News preview line here. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Read more